Breast cancer risk prediction with a modified BOADICEA model in Danish women
The modified BOADICEA risk model provided valid risks among a large retrospective cohort of Danish women.
Authors
- Søren Brunak (ORCID: https://orcid.org/0000-0003-0316-5866)
- Ilse Vejborg (ORCID: https://orcid.org/0000-0002-2329-203X)
- Erik Sørensen (ORCID: https://orcid.org/0000-0002-5002-9077)
- Rikke Louise Jacobsen (ORCID: https://orcid.org/0000-0002-7988-7964)
- Lorenzo Ficorella (ORCID: https://orcid.org/0000-0002-0577-1571)
- Henrik Hjalgrim (ORCID: https://orcid.org/0000-0002-4436-6798)
- Peter Christoffer Holm (ORCID: https://orcid.org/0000-0003-3363-5611)
- Timo Röder (ORCID: https://orcid.org/0000-0001-6841-4056)
- Michael Schwinn (ORCID: https://orcid.org/0000-0002-6151-369X)
- My von Euler‐Chelpin (ORCID: https://orcid.org/0000-0003-2204-7048)
- Sif Ingibergsdóttir Novitski
- Ole Birger Pedersen (ORCID: https://orcid.org/0000-0003-2312-5976)
- Sisse Rye Ostrowski (ORCID: https://orcid.org/0000-0001-5288-3851)
- Karina Banasik (ORCID: https://orcid.org/0000-0003-2489-2499)
- Þórunn Rafnar (ORCID: https://orcid.org/0000-0003-0491-7046)
- Bitten Aagaard (ORCID: https://orcid.org/0000-0001-8306-1332)
- Stig E. Bojesen (ORCID: https://orcid.org/0000-0002-4061-4133)
- Elsebeth Lynge (ORCID: https://orcid.org/0000-0003-4785-5236)
- Nasim Mavaddat
- Antonis C Antoniou
- Kari Stefansson
- Christian Erikstrup
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- deCODE Genetics (Iceland) (IS)
- Aarhus University (DK)
- University of Cambridge (GB)
- Aalborg University Hospital (DK)
- Novo Nordisk Foundation (DK)
- Hvidovre Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Danish Cancer Society (DK)
- Zealand University Hospital Køge (DK)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1038/s41416-025-03247-3
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk
- Region Hovedstaden
- Novo Nordisk Fonden